Court Decisions, ANDA Approvals, and 180-Day Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act
Detailed guidance document from FDA and regulatory agencies.
Document Details
Unknown
March 27, 2000
December 1, 2018
4d91b564-120c-4376-be51-25fecf8aa7a3
Related Documents
Implementation of Section 120 of the Food and Drug Administration Modernization Act of 1997-Advisory Committees
UnknownOctober 1, 1998Center for Drug Evaluation and Research
Standards for the Prompt Review of Efficacy Supplements, Including Priority Efficacy Supplements : Guidance for Industry
UnknownMay 1, 1998Center for Drug Evaluation and Research
180-Day Generic Drug Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act
UnknownJune 1, 1998Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.